Crism Therapeutics

(LSE) CRTX

Current Price£0.11

Market Cap£5.69M

Since IPO (2006)-91%

5 Year-96%

1 Year-54%

1 Month-13%

Crism Therapeutics Financials at a Glance

Market Cap

£5.69M

Revenue (TTM)

£17.70K

Net Income (TTM)

-£1.62M

EPS (TTM)

-£0.05

P/E Ratio

-2.25

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Price

£0.11

Volume

1,444

Open

£0.10

Price

£0.11

Volume

1,444

Open

£0.10

Previous Close

£0.11

Daily Range

£0.10 - £0.11

52-Week Range

£0.08 - £0.25

Estimated Earnings Date

Jun 12, 2026

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Price

£0.11

Volume

1,444

Open

£0.10

Previous Close

£0.11

Daily Range

£0.10 - £0.11

52-Week Range

£0.08 - £0.25

Estimated Earnings Date

Jun 12, 2026

CRTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Crism Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

Andrew James Webb

Website

www.crismtherapeutics.com

Headquarters

Road Town, VG

CRTX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-88%

Return on Capital

-1%

Return on Assets

-88%

Earnings Yield

-44.44%

Dividend Yield

0.00%

Payout Ratio

-3.07%

Stock Overview

Market Cap

£5.69M

Shares Outstanding

54.24M

Volume

1.44K

Avg. Volume

198.32K

Financials (TTM)

Gross Profit

£16.78K

Operating Income

-£465.07K

EBITDA

-£452.28K

Operating Cash Flow

-£933.00K

Capital Expenditure

-£28.00K

Free Cash Flow

-£961.00K

Cash & ST Invst.

£1.28M

Total Debt

£0.00

Crism Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

£0.00

N/A

Gross Profit

-£3.02K

-138.5%

Gross Margin

0.00%

N/A

Market Cap

£5.69M

N/A

Market Cap/Employee

£1.42M

N/A

Employees

N/A

Net Income

-£936.62K

-447.9%

EBITDA

-£906.41K

-544.8%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

£351.49K

-95.2%

Total Debt

£0.00

N/A

Accounts Receivable

£0.00

-100.0%

Inventory

£0.00

N/A

Long Term Debt

£0.00

-100.0%

Short Term Debt

£0.00

-100.0%

Return on Assets

-87.60%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

-£875.19K

+60.0%

Operating Cash Flow

-£875.19K

+60.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TRX.LTissue Regenix Group plc

TRX.LTissue Regenix Group plc£0.07+0.00%

TCF.LTheracryf Plc

TCF.LTheracryf Plc£0.00+0.00%

PRM.LProteome Sciences plc

PRM.LProteome Sciences plc£0.02+0.00%

N4P.LN4 Pharma Plc

N4P.LN4 Pharma Plc£0.00+0.00%

OBD.LOxford BioDynamics Plc

OBD.LOxford BioDynamics Plc£0.00+0.28%

FDBK.LFeedback plc

FDBK.LFeedback plc£0.08+0.00%

CHLL.LChill Brands Group PLC

CHLL.LChill Brands Group PLC£0.03+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

INTCIntel

INTCIntel$124.57+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About CRTX

What is the current price of Crism Therapeutics?

Crism Therapeutics is trading at £0.11 per share.

What is the 52-week range for Crism Therapeutics?

Over the past 52 weeks, Crism Therapeutics has traded between £0.08 and £0.25.

How much debt does Crism Therapeutics have?

As of the most recent reporting period, Crism Therapeutics reported total debt of £0.00.

How much cash does Crism Therapeutics have on hand?

Crism Therapeutics reported £1.28M in cash and cash equivalents in its most recent financial results.

What is Crism Therapeutics’s dividend yield?

Crism Therapeutics does not currently have a dividend yield.

Crism Therapeutics

Crism Therapeutics Financials at a Glance

CRTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Crism Therapeutics

CRTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Crism Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CRTX

What is the current price of Crism Therapeutics?

What is the 52-week range for Crism Therapeutics?

How much debt does Crism Therapeutics have?

How much cash does Crism Therapeutics have on hand?

What is Crism Therapeutics’s dividend yield?

Premium Investing Services